Pfizer Comes Back Into Buy Consideration

Pfizer (PFE) has been a strong contributor to our portfolios in the past and has come back on the radar screen when it dipped briefly below the 80%FV floor.

It now stands just a hair above this floor at 80.7%FV. EPS are expected to improve over the next 12 months and provides a dividend of 4.06%.

Pfizer is a Core stock. You can see our chart at: https://www.tradingview.com/chart/0AzDtHWc/.

By | 2016-02-19T08:11:11+00:00 February 19th, 2016|Categories: Money Basics|0 Comments

About the Author:

Steven Albrecht was the President and CEO of Charter Trust Company from 2001-2016

Leave A Comment